This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Harvard College, Zikani Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,071 
1 out of 1 Years Active: 2026
Title: Thomas Lepitre: Innovator in Macrolide Research
Introduction
Thomas Lepitre is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides for treating infectious diseases. His innovative work has the potential to impact the medical community positively.
Latest Patents
Lepitre holds a patent for "C10-alkylene substituted 13-membered macrolides and uses thereof." This patent describes 13-membered macrolides that are specifically designed for the treatment of infectious diseases. The macrolides detailed in his patent are azaketolides, which are crucial for addressing infections caused by Gram-negative bacteria. The patent also outlines methods for preparing these macrolides and pharmaceutical compositions that incorporate them.
Career Highlights
Throughout his career, Thomas Lepitre has worked with various organizations, including Zikani Therapeutics, Inc. and Harvard College. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Philip Hogan and Md Ataur Rahman. Their collaborative efforts have further advanced the research and development of macrolides.
Conclusion
Thomas Lepitre's work in the field of macrolides exemplifies the importance of innovation in addressing public health challenges. His contributions are paving the way for new treatments for infectious diseases, showcasing the vital role of inventors in the pharmaceutical industry.